查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1182123

全球口乾症（口乾病）治療藥物市場規模及預測：按類型、產品、分銷渠道和地區分析，2022-2029 年

Global Xerostomia Therapeutics Market Size study & Forecast, by Type, Product, Distribution Channel, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

口乾是一種影響口腔唾液分泌，導致口腔乾燥的疾病。

這種疾病會對身體功能產生不利影響，例如進食、說話和消化。他們也可能變得營養不良並對身體產生不利影響。高劑量藥物、抗抑鬱藥、安眠藥和抗炎藥是導致這些疾病的原因。市場增長受到關鍵因素的支持，例如在癌症治療中越來越多地採用化學療法和放射療法，乾燥綜合徵、艾滋病毒、糖尿病和阿爾茨海默氏病等疾病的患病率增加，以及老年人口的增加。

美國疾病控制與預防中心 (CDC) 估計，每年約有 650,000 名癌症患者在門診腫瘤診所接受化療。此外，還有一項名為“糖尿病性口乾症人工唾液（ASDIX）”的研究。2020 年 7 月發表的“Aldiamed 與安慰劑雙盲研究”得出結論，Aldiamed 噴霧劑在治療 1 型和 2 型糖尿病患者的口乾方面優於安慰劑。這些研究證明了人工唾液補充劑在治療口乾症方面的有效性。然而，缺乏有效治療方法阻礙了整個 2022-2029 年預測期內的市場增長。

全球口乾症（口乾病）藥物市場研究中考慮的主要區域是亞太地區、北美、歐洲、中美洲和南美洲以及世界其他地區。由於口乾症患病率上升、艾滋病毒感染率上升以及提高口乾意識活動，北美在整體市場份額中處於領先地位。然而，由於糖尿病等疾病的患病率上升和醫療保健成本上升，預計亞太地區將成為增長最快的地區。

本研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。該報告旨在包括被調查國家工業的定性和定量方面。

它還提供了有關關鍵方面的詳細信息，例如將定義市場未來增長的驅動因素和挑戰。此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

目錄

第一章執行摘要

  • 市場快照
  • 2019-2029 年按細分市場的全球市場估計和預測
    • 2019-2029 年按地區分列的口乾症（口乾病）藥物市場
    • 2019-2029 年按類型分列的口乾症（口乾病）藥物市場
    • 2019-2029 年按產品分列的口乾症（口乾病）藥物市場
    • 口乾症（口乾病）治療市場：按分銷渠道，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第二章口乾症（口乾病）藥物的全球市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 產業進化
  • 調查目標年份
  • 貨幣兌換率

第 3 章口乾症（口乾病）藥物的全球市場動態

  • 口乾症（口乾症）藥物市場影響分析（2019-2029）
    • 市場驅動力
      • 在癌症治療中越來越多地採用化學療法和放射療法
      • 乾燥綜合徵、艾滋病毒、糖尿病和阿爾茨海默病等疾病的患病率上升
      • 老年人口增加
    • 市場挑戰
      • 缺乏有效的治療方法
    • 市場機會
      • 啟動研發活動
      • 增加新品引進

第四章口乾症（口乾病）治療藥物的全球市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手之間的競爭
  • 波特五力模型的未來方法（2019-2029）
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術的
  • 招商引資模式
  • 分析師結論/建議
  • 頂級投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的整體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

6. 全球口乾症（口乾病）治療市場，按類型分類

  • 市場快照
  • 全球口乾症（口乾病）治療市場：按類型、性能潛力分析
  • 2019-2029 年全球口乾（口乾病）藥物市場按類型估算和預測
  • 口乾症（口乾病）治療藥物市場，細分分析
    • 人工唾液/唾液替代品
    • 唾液分泌興奮劑

7 全球口乾症（口乾病）藥物市場，副產品

  • 市場快照
  • 全球口乾症（口乾病）治療藥物市場：按產品分類的性能潛力分析
  • 2019-2029 年全球口乾症（口乾病）藥物市場、按產品估算和預測
  • 口乾症（口乾病）治療藥物市場，細分分析
    • 藥物
    • 唾液腺
    • 其他產品類型

8 全球口乾症（口乾病）藥物市場，按分銷渠道

  • 市場快照
  • 全球口乾症（口乾病）治療藥物市場：分銷渠道的性能潛力分析
  • 2019-2029 年全球口乾（口乾病）治療藥物市場，按分銷渠道估計和預測
  • 口乾症（口乾病）治療藥物市場，細分分析
    • 醫院藥房
    • 零售藥店
    • 網上藥店

9 全球口乾症（口乾病）藥物市場：區域分析

  • 口乾症（口乾病）治療藥物市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按類型劃分的估計和預測，2019-2029
      • 2019-2029 年各產品的估計和預測
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲口乾症（口乾病）藥物市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 歐洲其他地區
  • 亞太地區口乾症（口乾病）藥物市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲口乾症（口乾病）藥物市場概況
    • 巴西
    • 墨西哥
  • 世界其他地區

第 10 章 競爭信息

  • 頂級市場戰略
  • 公司簡介
    • Lupin Limited
      • 主要信息
      • 概述
      • 財務信息（視數據可用性而定）
      • 產品概要
      • 最近的發展
    • Quest Products, Inc.
    • Parnell Pharmaceuticals, Inc.
    • Fresenius SE & Co. KGaA
    • Hikma Pharmaceuticals PLC
    • Sun Pharmaceutical Industries Ltd
    • GlaxoSmithKline PLC
    • ADVANZ PHARMA Corp. Limited
    • Pharmascience Inc
    • Synedgen, Inc.

第十一章調查過程

  • 調查過程
    • 數據挖掘
    • 分析
    • 市場估計
    • 驗證
    • 出版物
  • 調查屬性
  • 調查先決條件

Global Xerostomia (Dry Mouth Disease) Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.25% over the forecast period 2022-2029. A medical disorder known as dry mouth causes the mouth to become dry by affecting saliva production in the mouth. Body functions including eating, speaking, and digestion may be negatively impacted by this disorder. Malnutrition may result from this and have a harmful effect on the body. High dosage pharmaceuticals, antidepressants, hypnotics, anti-inflammatory meds, and other substances are the cause of these diseases. The market growth is supported by significant factors such as increasing adoption of chemotherapy and radiotherapy in cancer treatment, growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others and a growing geriatric population base.

The Centers for Disease Control and Prevention (CDC) estimate that each year, around 650,000 cancer patients get chemotherapy in an ambulatory oncology clinic. Additionally, a study named "Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed Versus Placebo" that was released in July 2020 concluded that Aldiamed spray was superior to a placebo in treating xerostomia in people with type 1 and type 2 diabetes. These studies show that the use of artificial saliva replacements in the treatment of xerostomia is effective. However, the nonavailability of effective treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Xerostomia (Dry Mouth Disease) Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the overall market share owing to the increasing prevalence of xerostomia and increase in HIV disease coupled with the increase in dry mouth awareness initiatives. However, Asia Pacific is expected to be the fastest growing region due to the rising prevalence of diseases such as diabetes and growing healthcare expenditure.

Major market players included in this report are:

Lupin Limited

Quest Products, Inc.

Parnell Pharmaceuticals, Inc.

Fresenius SE & Co. KGaA

Hikma Pharmaceuticals PLC

Sun Pharmaceutical Industries Ltd

GlaxoSmithKline PLC

ADVANZ PHARMA Corp. Limited

Pharmascience Inc

Synedgen, Inc.

Recent Developments in the Market:

In April 2021, Parnell Pharmaceuticals, Inc. launched the Mouth Kote-MD mouthwash based on MycoDelens, a proprietary substance created and licenced by New Mexico Tech University.

Virginia Head & Neck Therapeutics, Inc. introduced Voutia in February 2021, a medication that continuously relieves xerostomia (commonly known as chronic dry mouth). For the millions of people who experience this painful and frequently disabling illness, the unique, FDA-approved device provides a whole new strategy.

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Product, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

By Type:

Drugs

Salivary Pens

Other Product Types

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product, 2019-2029 (USD Billion)
    • 1.2.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Dynamics

  • 3.1. Xerostomia (Dry Mouth Disease) Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing adoption of chemotherapy and radiotherapy in cancer treatment
      • 3.1.1.2. Growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others.
      • 3.1.1.3. Growing geriatric population base
    • 3.1.2. Market Challenges
      • 3.1.2.1. Nonavailability of effective treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing research and development activities
      • 3.1.3.2. Rising introduction of novel products

Chapter 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Type, Performance - Potential Analysis
  • 6.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Artificial Saliva/Saliva Substitutes
    • 6.4.2. Salivary Stimulants

Chapter 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Product, Performance - Potential Analysis
  • 7.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 7.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Drugs
    • 7.4.2. Salivary Pens
    • 7.4.3. Other Product Types

Chapter 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy

Chapter 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Analysis

  • 9.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.2.1. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.3.1. U.K. Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.2. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.3. France Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.4. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.5. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.6. Rest of Europe Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.4.1. China Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.2. India Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.3. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.4. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.5. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.5. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.5.1. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.5.2. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.6. Rest of The World Xerostomia (Dry Mouth Disease) Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Lupin Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Quest Products, Inc.
    • 10.2.3. Parnell Pharmaceuticals, Inc.
    • 10.2.4. Fresenius SE & Co. KGaA
    • 10.2.5. Hikma Pharmaceuticals PLC
    • 10.2.6. Sun Pharmaceutical Industries Ltd
    • 10.2.7. GlaxoSmithKline PLC
    • 10.2.8. ADVANZ PHARMA Corp. Limited
    • 10.2.9. Pharmascience Inc
    • 10.2.10. Synedgen, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, report scope
  • TABLE 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, research methodology
  • FIG 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, key trends 2021
  • FIG 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, porters 5 force model
  • FIG 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, pest analysis
  • FIG 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, value chain analysis
  • FIG 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable